Furthermore, the results of this study provide a basis for further investigations into the underlying mechanisms linking visfatin to the pathogenesis of AMI and AF, which may lead to the development of novel therapeutic strategies for these conditions. This evidence concerns the gene NAMPT and atrial fibrillation.